DAVENPORT & Co LLC Sells 5,068 Shares of Agilent Technologies, Inc. $A

DAVENPORT & Co LLC lessened its holdings in Agilent Technologies, Inc. (NYSE:A) by 2.0% during the fourth quarter, Holdings Channel.com reports. The firm owned 248,166 shares of the medical research company’s stock after selling 5,068 shares during the quarter. DAVENPORT & Co LLC’s holdings in Agilent Technologies were worth $33,946,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also made changes to their positions in the business. Bridgefront Capital LLC bought a new stake in Agilent Technologies in the third quarter worth $1,323,000. Envestnet Asset Management Inc. increased its holdings in shares of Agilent Technologies by 3.8% during the third quarter. Envestnet Asset Management Inc. now owns 607,914 shares of the medical research company’s stock valued at $78,026,000 after acquiring an additional 22,498 shares in the last quarter. CCLA Investment Management increased its holdings in shares of Agilent Technologies by 10.5% during the third quarter. CCLA Investment Management now owns 1,027,970 shares of the medical research company’s stock valued at $131,909,000 after acquiring an additional 97,312 shares in the last quarter. Wellington Management Group LLP raised its position in shares of Agilent Technologies by 4.8% in the 3rd quarter. Wellington Management Group LLP now owns 9,380,521 shares of the medical research company’s stock worth $1,203,990,000 after purchasing an additional 433,342 shares during the last quarter. Finally, Osaic Holdings Inc. raised its position in shares of Agilent Technologies by 35.5% in the 2nd quarter. Osaic Holdings Inc. now owns 68,053 shares of the medical research company’s stock worth $8,017,000 after purchasing an additional 17,817 shares during the last quarter.

Agilent Technologies Stock Performance

Shares of A stock opened at $114.16 on Wednesday. The company has a 50 day moving average price of $125.50 and a 200-day moving average price of $135.25. Agilent Technologies, Inc. has a 52 week low of $96.43 and a 52 week high of $160.27. The firm has a market capitalization of $32.26 billion, a PE ratio of 25.20, a P/E/G ratio of 2.36 and a beta of 1.31. The company has a quick ratio of 1.59, a current ratio of 2.07 and a debt-to-equity ratio of 0.44.

Agilent Technologies (NYSE:A) last released its quarterly earnings data on Wednesday, February 25th. The medical research company reported $1.36 earnings per share for the quarter, missing the consensus estimate of $1.37 by ($0.01). The company had revenue of $1.80 billion for the quarter, compared to analysts’ expectations of $1.81 billion. Agilent Technologies had a net margin of 18.26% and a return on equity of 24.49%. The firm’s revenue for the quarter was up 7.0% on a year-over-year basis. During the same period in the previous year, the firm earned $1.31 earnings per share. Agilent Technologies has set its FY 2026 guidance at 5.900-6.040 EPS and its Q2 2026 guidance at 1.390-1.420 EPS. As a group, equities research analysts expect that Agilent Technologies, Inc. will post 5.58 earnings per share for the current year.

Agilent Technologies Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, April 22nd. Shareholders of record on Tuesday, March 31st will be issued a $0.255 dividend. The ex-dividend date of this dividend is Tuesday, March 31st. This represents a $1.02 dividend on an annualized basis and a yield of 0.9%. Agilent Technologies’s dividend payout ratio is currently 22.52%.

Wall Street Analysts Forecast Growth

Several analysts recently commented on the stock. JPMorgan Chase & Co. increased their price objective on shares of Agilent Technologies from $165.00 to $180.00 and gave the company an “overweight” rating in a research report on Tuesday, November 25th. Evercore upgraded shares of Agilent Technologies from an “in-line” rating to an “outperform” rating and upped their target price for the stock from $155.00 to $160.00 in a research note on Monday, January 5th. UBS Group cut their price target on shares of Agilent Technologies from $180.00 to $165.00 and set a “buy” rating on the stock in a report on Thursday, February 26th. The Goldman Sachs Group assumed coverage on shares of Agilent Technologies in a research report on Tuesday, December 9th. They set a “buy” rating and a $170.00 price target for the company. Finally, Citigroup boosted their price objective on shares of Agilent Technologies from $165.00 to $185.00 and gave the stock a “buy” rating in a report on Tuesday, November 25th. Two research analysts have rated the stock with a Strong Buy rating, eleven have issued a Buy rating and three have assigned a Hold rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $161.20.

Agilent Technologies Company Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett?Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.